Release Date: 27/01/15 08:29 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 34.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%